SEARCH

SEARCH BY CITATION

References

  • 1
    Healthy People 2010. http://www.healthy-people.gov. Accessed March 28, 2008.
  • 2
    Betancourt JR, Maina AW. The Institute of Medicine report “Unequal Treatment”: implications for academic health centers. Mt Sinai J Med. 2004;71(5):314321.
  • 3
    Greene EL, Thomas CR. Minority health and disparities-related issues: part II. Med Clin North Am. 2005;89(5):xixii.
  • 4
    American Heart Association. Heart Disease and Stroke Statistics—2008 Update. Dallas, TX: American Heart Association; 2008.
  • 5
    Christian AH, Rosamond W, White AR, et al. Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study. J Women's Health. 2007;16(1):6881.
  • 6
    Centers for Disease Control Web site. Obesity Trends. http://www.cdc.gov/nccdphp/dnpa/obesity/trend/index.htm. Accessed March 28, 2008.
  • 7
    DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173194.
  • 8
    Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998;20:157172.
  • 9
    Third Report of the of the National Cholesterol Education Program (NCEP) expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health; September 2002. NIH publication 02–5215.
  • 10
    Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:27352752.
  • 11
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults, findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356359.
  • 12
    Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome, prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163:427436.
  • 13
    Haffner SM, D'Agostino R, Goff D, et al. LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 1999;19(9):22342240.
  • 14
    Metcalf PA, Sharrett AR, Folsom AR, et al. African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1998;148(8):750760.
  • 15
    Appel SJ, Floyd NA, Giger JN, et al. African American women, metabolic syndrome, and national cholesterol education program criteria, a pilot study. Nurs Res. 2005;54(5):339346.
  • 16
    Marcovina SM, Albers JJ, Wijsman E, et al. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white American. J Lipid Res. 1996;37(12):25692585.
  • 17
    Sumner AE, Finley KB, Genovese DJ, et al. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med. 2005;165(12):13951400.
  • 18
    Taylor H, Liu J, Wilson G, et al. Distinct component profiles and high risk among African Americans with the metabolic syndrome: the Jackson Heart Study. Diabetes Care. 2008 Mar 10 [Epub ahead of print].
  • 19
    Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am. 2004;33:333350.
  • 20
    Hunt KJ, Resendez RG, Williams K, et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004;110:12511257.
  • 21
    Lonnqvist F, Thorne A, Large V, et al. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol. 1997;17:14721480.
  • 22
    Thom T, Haase N, Rosamond W, et al. Heart Disease and Stroke Statistics—2006 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85e151.
  • 23
    Smith SC Jr, Clark LT, Cooper RS, et al. Discovering the full spectrum of cardiovascular disease, minority health summit 2003, report of the obesity, metabolic syndrome and hypertension writing group. Circulation. 2005;111:e134e139.
  • 24
    Abell JE, Egan BM, Wilson PW, et al. Age and race impact the association between BMI and CVD mortality in women. Public Health Rep. 2007;122(4):507512.
  • 25
    Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA. 2003;289:187193.
  • 26
    Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention of metformin. N Engl J Med. 2002;346:393403.
  • 27
    Appel LJ, Moore TJ, Obarzanek E, et al; DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:11171124.
  • 28
    Elmer PJ, Obarzanek E, Vollmer WM, et al; PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006;144:485495.
  • 29
    Boyington JE, Carter-Edwards L, Piehl M, et al. Cultural attitudes toward weight, diet, and physical activity among overweight African American girls. Prev Chronic Dis. 2008;5(2):A36.